Our high-resolution single-cell multiomics maps suggest how to probe and deconstruct heterogeneity of CML, thereby permitting inference of leukemic vs. non-leukemic cells, estimation of BCR::ABL1+ LSCs, enumeration of their molecular features, and prospective isolation. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.